kt 5823 has been researched along with 2,3,5,4'-tetrahydroxystilbene 2-o-glucopyranoside in 1 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (2,3,5,4'-tetrahydroxystilbene 2-o-glucopyranoside) | Trials (2,3,5,4'-tetrahydroxystilbene 2-o-glucopyranoside) | Recent Studies (post-2010) (2,3,5,4'-tetrahydroxystilbene 2-o-glucopyranoside) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 127 | 0 | 101 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XF; Huang, YJ; Lin, DY; Xu, XL; Zhang, W | 1 |
1 other study(ies) available for kt 5823 and 2,3,5,4'-tetrahydroxystilbene 2-o-glucopyranoside
| Article | Year |
|---|---|
2,3,4',5-tetrahydroxystilbene-2-O-β-D-glucoside inhibits proliferation of vascular smooth muscle cells: involvement of NO/cGMP/PKG pathway.
Topics: Animals; Becaplermin; Carbazoles; Cell Cycle; Cell Proliferation; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Glucosides; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxadiazoles; Polygonum; Proto-Oncogene Proteins c-sis; Quinoxalines; Rats; Rats, Sprague-Dawley; Signal Transduction; Stilbenes | 2012 |